TrialBMC nephrology2023

Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial.

Iman Ibrahim Sarhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.